Guide · Clinical Safety & Operations
Post-Deployment Healthcare AI Monitoring
The half of AI evaluation that happens after go-live. A structured framework for catching drift, bypass, and silent failure before they erode clinical value.
Why deployed healthcare AI fails silently
The riskiest period in any healthcare AI deployment is the year after the procurement decision is signed off. Attention shifts to the next initiative. The vendor reports look reassuring. The dashboard, if there is one, sits behind a login nobody opens. Meanwhile the model is meeting reality.
Deployed AI does not fail in a single dramatic moment. It fails slowly. Patient populations shift, and the model starts to encounter cases unlike its training data. Clinicians try the output, do not trust it, quietly stop using it. A vendor pushes an update, and behaviour changes in ways nobody catches. Six months later the AI is still nominally in production and has stopped delivering value.
Effective post-deployment monitoring is not a compliance exercise. It is the work that protects the original investment from the failure modes nobody wants to think about at procurement time.
What good monitoring covers
Good monitoring goes beyond model accuracy. It covers four distinct failure modes that need separate detection: model performance drift, population drift, workflow drift, and the discontinuities introduced by vendor model version updates. Each of these has a different signal, a different timeframe, and a different appropriate response. Treating them as one signal is why most monitoring regimes miss the failures they were set up to catch.
A framework for post-deployment AI monitoring
Six stages, designed to be set up at deployment and run continuously afterwards.
Define monitoring scope at deployment, not after
What gets monitored has to be agreed before go-live, not bolted on later. Scope includes: which performance metrics, what threshold triggers a review, which workflow signals (bypass rate, override rate, time per case), what counts as a safety event. Defining this after deployment means you start without a baseline and end up arguing about thresholds when the data already looks bad.
Establish a post-deployment baseline
The pre-procurement baseline tells you what the world looked like before AI. The post-deployment baseline tells you what the AI is actually doing in your live setting, in the first weeks of real use. These are different numbers. Real-world performance often diverges from internal validation, and the post-deployment baseline is what every future measurement should be compared to.
Track performance continuously
Dashboards over reports. Performance metrics should be visible to the people responsible for the AI on a continuous basis, not packaged into a quarterly slide deck. Continuous tracking surfaces drift early, before it shows up in incident reviews. This requires data flow from the live AI into a monitoring layer the vendor does not control.
Detect drift across populations and time
Drift takes several forms. Population drift: your case mix changes, and the AI encounters inputs unlike its training data. Performance drift: accuracy slowly degrades over time. Workflow drift: the way the AI is used changes, often without anyone noticing. Effective monitoring detects each separately and reports them as different problems with different responses.
Track bypass and override behaviour
Bypass rate is one of the most underused signals in healthcare AI. If clinicians stop using the tool, or systematically override its outputs, the model could be performing perfectly and still delivering zero value. A rising bypass rate is almost always the earliest signal that something has gone wrong. Most vendor dashboards do not report it.
Re-evaluate against the original baseline
Continuous monitoring is necessary but not sufficient. At least annually, and after every model version update, run a structured re-evaluation against the original procurement baseline. This is the test of whether the AI is still doing what it was bought to do. The output is a clear continue, retrain, redesign, or retire decision.
The four failure modes monitoring needs to catch
Drift is not one signal. It is four distinct phenomena with different timeframes and responses.
Performance drift
Slow degradation in accuracy, sensitivity, or specificity over time, even with the same model. Detected by continuous tracking against the post-deployment baseline.
Population drift
Your patient mix evolves; the AI encounters cases unlike its training data. Often the cause behind performance drift, requires its own monitoring.
Workflow drift
How the tool is used changes over time. Bypass rates, override patterns, and time-per-case shifts that vendor dashboards rarely surface.
Model version changes
Vendors push updates. Each update is effectively a new tool, requiring a fresh round of validation before it is trusted in production.
Common pitfalls
The patterns we see most often when post-deployment monitoring fails to catch real problems.
Treating monitoring as compliance, not value protection
A box-ticking monitoring regime that produces a quarterly report nobody reads will not catch drift in time. Monitoring exists to protect the value of an AI investment that someone signed off, not to satisfy an audit.
Relying only on vendor-supplied monitoring
Vendor dashboards see the model. They do not see clinician bypass, workflow drift, or downstream outcomes. Independent monitoring covers what vendor systems are not designed to surface.
Watching the model, ignoring the workflow
Most failed AI deployments do not fail because the model broke. They fail because clinicians stopped using it, or used it differently than intended. Monitoring that only tracks model performance misses this entirely.
Not having a stop trigger agreed in advance
Decisions to pull or retrain a deployed AI tool are politically difficult once the tool is in clinical use. Pre-defined thresholds, agreed at deployment, take that pressure off the moment of decision.
Who should own post-deployment monitoring
Monitoring tends to fall between roles, which is why it so often does not happen well. A working model includes:
- Clinical safety for incident review, hazard tracking, and the link to the safety case.
- Informatics for the data flow that makes continuous monitoring possible.
- The clinical lead for the pathway for sense-checking what the data is showing.
- Vendor management for the contractual side of model updates and incident escalation.
- An independent evaluator for periodic re-evaluation against the original procurement baseline, especially after model version updates.
The independent role matters most for re-evaluation. Vendor-funded monitoring of a vendor product is rarely accepted as evidence by clinical safety committees or boards.
Frequently asked questions
Related guides
Healthcare AI Procurement
Decisions made before deployment shape what monitoring needs to catch.
Read guideHealthcare AI ROI
Monitoring data is the raw material for any defensible ROI report.
Read guideHealthcare AI Readiness
Readiness covers the conditions that make ongoing monitoring possible at all.
Read guideCatch AI failure before it costs you
Independent re-evaluation of deployed AI against its original baseline. The work that protects the value of an investment that has already been made.